Free Trial

Nabriva Therapeutics (NBRV) News Today

Nabriva Therapeutics logo

NBRV Latest News

Nabriva Therapeutics plc (NBRVF)
Nabriva Therapeutics PLC NBRVF
NBRV - Nabriva Therapeutics plc
Nabriva Therapeutics (Nasdaq:NBRV) Headline
Trading was temporarily halted for "NBRV" at 09:03 AM with a stated reason of "LULD pause."...
NBRV Nabriva Therapeutics plc
Nabriva Therapeutics Provides Corporate Update
Nabriva Adds 9% On Positive Results From Study Of Xenleta In Cystic Fibrosis
Nabriva's stock is up after sharing antibiotic news
Nabriva Inks Exclusive Distribution Agreement With Er-Kim
A Preview Of Nabriva Therapeutics's Earnings
Nabriva Therapeutics Earnings, Revenue Miss in Q1
Nabriva 4Q results indicate slowdown in topline growth
Get Nabriva Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBRV and its competitors with MarketBeat's FREE daily newsletter.

NBRV Media Mentions By Week

NBRV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NBRV
News Sentiment

0.00

0.50

Average
Medical
News Sentiment

NBRV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NBRV Articles
This Week

0

0

NBRV Articles
Average Week

Get Nabriva Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBRV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NBRV) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners